Hepatitis Monthly

Published by: Kowsar

The Efficacy and Safety of Peginterferon Alpha-2a (PEGASYS) monotherapy in the Treatment of Chronic Hepatitis C Infected Subjects with Transfusion Dependent Thalassemia

Shahram Mirmomen 1 , * , Naser Ebrahimi Daryani 2 , Reza Malekzadeh 2 , Mohammad Reza Zali 2 , Babak Haghpanah 2 , Parisa Poursamimi 2 , Sayid Hashemi 2 and Seyed Moayed Alavian 2
Authors Information
1 Shahid Beheshti University of Medical Sciences, Taleghani general Hospital & Study Group of Interferon in Iran (SG.IFN.IR), mirmomen@ams.ac.ir, Tehran, IR.Iran
2 Shahid Beheshti University of Medical Sciences, Taleghani general Hospital & Study Group of Interferon in Iran (SG.IFN.IR), Tehran, IR.Iran
Article information
  • Hepatitis Monthly: 4 (7); 65-70
  • Article Type: Research Article

To Cite: Mirmomen S, Daryani N, Malekzadeh R, Zali M, Haghpanah B, et al. The Efficacy and Safety of Peginterferon Alpha-2a (PEGASYS) monotherapy in the Treatment of Chronic Hepatitis C Infected Subjects with Transfusion Dependent Thalassemia, Hepat Mon. Online ahead of Print ; 4(7):65-70.

Abstract
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments